ProKidney Corp.
PROK
$1.67
-$0.04-2.34%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 190.52% | 1,075.00% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 190.52% | 1,075.00% | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 190.52% | 1,075.00% | -- | -- | -- |
| SG&A Expenses | -6.76% | 2.00% | 27.87% | 23.65% | 23.29% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.85% | -7.02% | 13.67% | 14.86% | 19.41% |
| Operating Income | 6.18% | 7.48% | -13.18% | -14.52% | -19.20% |
| Income Before Tax | 5.78% | 7.77% | -14.30% | -22.34% | -28.62% |
| Income Tax Expenses | -68.57% | 169.23% | 653.77% | -78.67% | -102.20% |
| Earnings from Continuing Operations | 5.83% | 7.18% | -16.60% | -19.59% | -23.97% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -13.88% | -19.11% | -3.03% | -6.93% | -1.07% |
| Net Income | -5.64% | -12.75% | -55.74% | -87.35% | -93.87% |
| EBIT | 6.18% | 7.48% | -13.18% | -14.52% | -19.20% |
| EBITDA | 6.80% | 8.38% | -12.73% | -13.89% | -18.51% |
| EPS Basic | 12.95% | 17.76% | 1.39% | 4.10% | -6.63% |
| Normalized Basic EPS | -661.07% | -232.38% | -145.16% | -122.53% | -104.56% |
| EPS Diluted | 12.95% | 17.76% | 1.39% | 4.10% | -6.63% |
| Normalized Diluted EPS | -661.07% | -232.38% | -145.16% | -122.53% | -104.56% |
| Average Basic Shares Outstanding | 19.99% | 36.41% | 60.18% | 96.49% | 83.44% |
| Average Diluted Shares Outstanding | 19.99% | 36.41% | 60.18% | 96.49% | 83.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |